ZW-39

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameZW-39
Drug Alias NameV-1 (Zymeworks)HER-2 modulator (Zymeworks)ZW-39
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 modulators
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsMetastatic breast cancerBrain Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesZymeworks Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZymeworks Inc
Active IndicationsN/A
Inactive IndicationsMetastatic breast cancerBrain Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A